Study to Assess the Efficacy and Safety of GF-001001-00 Cream in Secondarily-Infected Traumatic Lesions

NCT01005771 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondarily Infected Traumatic Lesions

Interventions

DRUG: GF-001001-00
DRUG: Placebo

Sponsor

Ferrer Internacional S.A.